Skip to main content
. 2017 Sep 29;16(21):2100–2107. doi: 10.1080/15384101.2017.1361071

Figure 1.

Figure 1

. The level of lncRNA XIST expression in LAD cells. (A) qRT-PCR analysis of lncRNA XIST expression levels in LAD patients' tumor tissues; (B) qRT-PCR analysis of lncRNA XIST expression levels in A549 and A549/DDP cells; (C) MTT assay of the IC50 values of A549 and A549/DDP cells to cisplatin; (D) qRT-PCR analysis of lncRNA XIST expression levels in XIST overexpression A549 cells; (E) MTT assay of the IC50 values of XIST overexpression A549 cells to cisplatin; (F) qRT-PCR analysis of lncRNA XIST expression levels in XIST knockdown A549/DDP cells; (G) MTT assay of the IC50 values of XIST knockdown A549/DDP cells to cisplatin. ** P < 0.01, ***P < 0.001.